Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997–2002
- 1.5k Downloads
Efforts to prevent leukemia have been hampered by an inability to identify significant risk factors. Exploring incidence patterns of leukemia subtypes by sex and race/ethnic group may generate new etiologic hypotheses and identify high-risk groups for further study.
Data from the North American Association of Central Cancer Registries for 1997–2002 were used to assess patterns of leukemia incidence by subtype, sex, age, race and ethnicity.
A total of 144,559 leukemia cases were identified, including 66,067 (46%) acute and 71,860 (50%) chronic leukemias. The highest rates of acute myeloid leukemia with and without maturation were observed in Asian-Pacific Islanders (API). Hispanics had a higher incidence of acute lymphocytic leukemia, particularly in childhood, and promyelocytic leukemia than did non-Hispanics. African–Americans had the highest rates of HTLV-1 positive adult T-cell leukemia/lymphoma. A sharp increase in the incidence of chronic myeloid leukemia was observed for both APIs and Hispanics, 85 years and older.
Known risk factors are unlikely to explain the observed disparities in leukemia incidence. Further studies of differences in environmental and genetic risk factors in these populations by specific leukemia subtype may provide clues to the etiologies of these malignancies.
KeywordsLeukemia Subtype Incidence Race Hispanic ethnicity Epidemiology
This project was supported in part by the Centers for Disease Control and Prevention under cooperative agreement U75/CCU515998 to the North American Association of Central Cancer Registries, and the National Cancer Institute’s Surveillance, Epidemiology, and End-Results Program under contract N01-CN-67001 from the National Institutes of Health, Department of Health and Human Services.
- 2.Ries LAG, Smith MA, Gurney JG et al (1999) Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. National Cancer Institute, SEER Program, Bethesda, MDGoogle Scholar
- 3.Ries LAG, Harkins D, Krapcho M et al (2006) SEER cancer statistics review, 1975–2003. National Cancer Institute, Bethesda, MarylandGoogle Scholar
- 5.Horm JW, Devesa SS, Burhansstipanov L (1996) Cancer incidence, mortality, and survival among racial and ethnic minority groups in the United States. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention. Oxford University Press, New YorkGoogle Scholar
- 12.Khalidi HS, Medeiros LJ, Chang KL, Brynes RK, Slovak ML, Arber DA (1998) The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. Am J Clin Pathol 109:211–220PubMedGoogle Scholar
- 14.Ellison JH, Wu XC, Howe HL et al (2005) Cancer in North America, 1998–2002. North American Association of Central Cancer Registries, Inc, Springfield, ILGoogle Scholar
- 15.NAAACCR Expert Panel in Hispanic Identification (2003) Report of the NAACCR Expert Panel on Hispanic Identification 2003. Springfield, IL: North American Association of Central Cancer RegistriesGoogle Scholar
- 16.Ellison JH, Wu XC, McLaughlin CC et al (2006) Cancer rates in North America, 1999–2003. North American Association of Central Cancer Registries, Springfield, ILGoogle Scholar
- 17.Fritz A, Percy C, Jack A et al (2000) International classification of diseases for oncology, 3rd edn, World Health Organization, GenevaGoogle Scholar
- 20.SEER*STAT (2006) Surveillance Research Program, National Cancer InstituteGoogle Scholar
- 26.Muir KR, Parkes SE, Mann JR, Stevens MC, Cameron AH (1992) Childhood cancer in the West Midlands: incidence and survival, 1980–1984, in a multi-ethnic population. Clin Oncol (R Coll Radiol) 4:177–182Google Scholar
- 36.Ruiz-Arguelles GJ, Garces-Eisele J, Reyes-Nunez V, Gomez-Rangel JD, Ruiz-Delgado GJ (2004) More on geographic hematology: the breakpoint cluster regions of the PML/RARalpha fusion gene in Mexican Mestizo patients with promyelocytic leukemia are different from those in Caucasians. Leuk Lymphoma 45:1365–1368PubMedCrossRefGoogle Scholar
- 40.Havener L (2006) The 2005 Summary of Quality Assessments of CINA Deluxe. North American Association of Central Cancer Registries, IncGoogle Scholar